Albireo Pharma Inc. buy Quitte
Start price
22.01.18
/
50%
€31.57
Target price
23.07.18
€36.08
Performance (%)
-6.83%
End price
23.07.18
€29.41
Summary
This prediction ended on 23.07.18 with a price of €29.41. With a performance of -6.83%, the BUY prediction by Quitte finished with a loss. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Albireo Pharma Inc. | - | - | - | - |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% | 55.750% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% | 80.820% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% | 49.596% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% | 55.940% |
Comments by Quitte for this prediction
In the thread Albireo Pharma Inc. diskutieren
alte Liebe
eine alte Liebe von mir, die wieder befeuert wird
https://seekingalpha.com/news/3323843-albireo-receive-55m-elobixibat-approval-japan
(Laufzeit überschritten)
Stopped prediction by Quitte for Albireo Pharma Inc.
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€24.20
22.08.19
22.08.19
€28.00
09.01.20
09.01.20
-1.57%
09.01.20
09.01.20
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€23.98
22.08.19
22.08.19
€38.80
04.11.21
04.11.21
6.84%
05.11.21
05.11.21
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€20.26
29.03.17
29.03.17
€25.89
29.09.17
29.09.17
-8.64%
29.09.17
29.09.17
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€9.03
12.07.16
12.07.16
€21.00
22.12.16
22.12.16
97.67%
22.12.16
22.12.16